Introduction
Perindopril, marketed under the brand name Aceon, is a medication primarily used to treat hypertension and coronary artery disease. It belongs to the class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. Aceon comes in tablet form with strengths of 2mg, 4mg, and 8mg for oral administration. This medication is prescribed to help lower blood pressure and reduce the risk of heart attacks in certain individuals with CAD. Understanding the proper dosage and strengths of Aceon is essential for its effectiveness and safety in managing these conditions.
Overview of Aceon and its Uses
Aceon, known generically as Perindopril, is a medication classified as an angiotensin-converting enzyme (ACE) inhibitor. It is commonly prescribed for the treatment of hypertension (high blood pressure) and coronary artery disease. Perindopril works by relaxing blood vessels, aiding in blood flow and reducing blood pressure. This medication is also utilized to lower the risk of heart attacks in individuals with coronary artery disease. Aceon is available in tablet form with strengths of 2mg٫ 4mg٫ and 8mg for oral administration.
Dosage Information
The dosage of Aceon, known as Perindopril, varies depending on the condition being treated. For hypertension, the usual starting dose is 4 mg to 8 mg per day٫ while for coronary artery disease٫ the initial dose may be 4 mg daily. Dosages may be adjusted based on individual response and tolerability. Aceon tablets come in strengths of 2mg٫ 4mg٫ and 8mg for oral administration. It is essential to follow the prescribed dosage guidelines provided by a healthcare professional for optimal effectiveness.
Recommended Dosage for Hypertension
For the treatment of hypertension, the typical dosage of Aceon (Perindopril) ranges from 4 mg to 8 mg per day taken orally٫ either as a single dose or split into two doses. The maximum recommended daily dose is 16 mg. It is crucial to adhere to the prescribed dosage and consult a healthcare provider for adjustments or guidance regarding the management of hypertension with Aceon.
Initial Dosing and Maintenance Dose for Coronary Artery Disease
For coronary artery disease, the initial dosing of Aceon (Perindopril) typically starts at 4 mg orally once a day for two weeks, followed by an increase to the maintenance dose as tolerated. The maintenance dose is often 8 mg once daily. Dosages may be adjusted based on individual response and the guidance of a healthcare provider to manage coronary artery disease effectively.
Specific Dosage Recommendations for Elderly Patients
Elderly patients are typically recommended an initial daily dose of 4 mg of Aceon (Perindopril), which can be given as a single dose or divided into two doses. The dosage may be adjusted based on individual response and tolerability, with a maximum dosage not exceeding 8 mg daily. It is crucial to follow healthcare provider recommendations for safe and effective use of Aceon in elderly individuals.
Strengths Available
Aceon, known as Perindopril, is available in tablet form with strengths of 2mg, 4mg, and 8mg for oral administration. Each tablet consists of perindopril erbumine along with inactive ingredients like colloidal silica, lactose, magnesium stearate, and microcrystalline cellulose. These varying strengths cater to different dosage requirements and offer flexibility in managing conditions like hypertension and coronary artery disease effectively.
Aceon Tablet Strengths
Aceon, or Perindopril, is available in tablet form with strengths of 2mg, 4mg, and 8mg for oral administration. Each tablet contains perindopril erbumine along with various inactive ingredients. It is important to adhere to the prescribed strengths of Aceon tablets for the appropriate management of conditions such as hypertension and coronary artery disease.
Inactive Ingredients in Aceon Tablets
Aceon tablets contain inactive ingredients along with perindopril erbumine. These inactive ingredients include colloidal silica (hydrophobic), lactose, magnesium stearate, and microcrystalline cellulose. It is important to be aware of these components in the medication for individuals who may have sensitivities or allergies to any of these ingredients.
10 responses to “Aceon Dosage and Strengths Information”
The article delivers a concise yet informative overview of Perindopril, known as Aceon, focusing on its primary uses in hypertension and coronary artery disease management. The explanation of its classification as an ACE inhibitor and the availability of tablet strengths in 2mg, 4mg, and 8mg is beneficial. The discussion on lowering blood pressure and decreasing the likelihood of heart attacks in specific CAD cases is well-detailed.
The article offers a clear overview of Perindopril (Aceon) and its significance in managing hypertension and coronary artery disease. The details on the tablet forms and strengths, including 2mg, 4mg, and 8mg, are well-presented. The focus on the medication
The article effectively introduces Perindopril (Aceon) as a valuable medication for hypertension and coronary artery disease. By categorizing it as an ACE inhibitor and explaining its tablet variations of 2mg, 4mg, and 8mg for oral use, the text provides a comprehensive understanding. The emphasis on reducing blood pressure and heart attack risks in CAD patients is well-articulated.
The article provides a comprehensive introduction to Perindopril, also known as Aceon, highlighting its primary uses in treating hypertension and coronary artery disease. It effectively explains its classification as an ACE inhibitor and the available tablet strengths for oral administration. The emphasis on lowering blood pressure and reducing the risk of heart attacks in individuals with CAD is commendable.
The article serves as an informative guide to Perindopril (Aceon), highlighting its essential role in managing hypertension and coronary artery disease. The breakdown of its classification as an ACE inhibitor and the tablet strengths available in 2mg, 4mg, and 8mg for oral administration is well-presented. The emphasis on reducing blood pressure and mitigating heart attack risks in individuals with CAD is well-detailed.
The article provides a comprehensive overview of Perindopril (Aceon) and its importance in managing hypertension and coronary artery disease. The explanation of its classification as an ACE inhibitor and the availability of tablet strengths in 2mg, 4mg, and 8mg is clear. The focus on lowering blood pressure and reducing the likelihood of heart attacks in specific CAD cases is well-structured.
The article serves as a valuable resource on Perindopril (Aceon), shedding light on its essential role in treating hypertension and coronary artery disease. The clarification regarding its classification as an ACE inhibitor and the tablet strengths offered in 2mg, 4mg, and 8mg is well-structured. The emphasis on reducing blood pressure and mitigating heart attack risks in individuals with CAD is well-articulated.
The article effectively outlines the significance of Perindopril, marketed as Aceon, in managing hypertension and coronary artery disease. By explaining its classification as an ACE inhibitor and the available tablet strengths of 2mg, 4mg, and 8mg for oral consumption, the text provides a comprehensive overview. The focus on lowering blood pressure and minimizing heart attack risks in specific CAD patients is well-presented.
The article offers a detailed introduction to Perindopril (Aceon), highlighting its crucial role in treating hypertension and coronary artery disease. The breakdown of its classification as an ACE inhibitor and the tablet strengths in 2mg, 4mg, and 8mg is informative. The emphasis on reducing blood pressure and lowering the risk of heart attacks in certain CAD individuals is well-articulated.
The article delivers a thorough introduction to Perindopril, also known as Aceon, emphasizing its primary uses in hypertension and coronary artery disease treatment. The clarification of its classification as an ACE inhibitor and the tablet strengths offered in 2mg, 4mg, and 8mg is beneficial. The discussion on lowering blood pressure and decreasing the risk of heart attacks in certain CAD patients is well-articulated.